Experimental study on Cervi Cornu on Adjuvant Arthritis in rats

Objective: To investigate effects of Cervi Cornu on Adjuvant Athritis in rats, the edema inhibit rate, the anaJgesic effects, the number of WBC, RA facter, Platelet, the quantity of CRP, total protein, albumin and globuline in the blood serum were measured in the arthritis part. Results: The results...

Full description

Saved in:
Bibliographic Details
Main Authors: Ji-Won, Shin (Author), Jai-Young, Park (Author), Hee-Soo, Park (Author)
Format: Book
Published: Korean Pharmacopuncture Institute, 2002-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_99b3436a7b2e4f1c85c1eb02d87e1192
042 |a dc 
100 1 0 |a Ji-Won, Shin  |e author 
700 1 0 |a Jai-Young, Park  |e author 
700 1 0 |a Hee-Soo, Park  |e author 
245 0 0 |a Experimental study on Cervi Cornu on Adjuvant Arthritis in rats 
260 |b Korean Pharmacopuncture Institute,   |c 2002-02-01T00:00:00Z. 
500 |a 10.3831/KPI.2002.5.1.113  
500 |a 2093-6966 
500 |a 2234-6856 
520 |a Objective: To investigate effects of Cervi Cornu on Adjuvant Athritis in rats, the edema inhibit rate, the anaJgesic effects, the number of WBC, RA facter, Platelet, the quantity of CRP, total protein, albumin and globuline in the blood serum were measured in the arthritis part. Results: The results obtained as fonows ; 1. After arthritis of Sprague dawley(SD) rats was induced by injecting Freund's complete adjuvant for 2 weeks, any treatment was not for Control group, acupunctured for Treat Ⅰ group. normal saJine was ora] administrated for the Treat Ⅱ group, Cervi Cornu Ex. was oral administrated for Treat Ⅲ, and Cervi Cornu Herbal-acupullcture was injected for Trea Ⅳ group during 2 weeks every other day. Selected point was on pressure pain point in both groups. And then the edema inhibit rate were checked. The edema inhibit rate was in Treat I group, Treat IV group, in Treat III. there was significance in the edema inhibit rate between Control group and Treat group, in order of Treat Ⅰ, Ⅳ, Ⅲ.(p<0.05) 2. The analgesic effects was (gm) in Control group. (gm) in Treat Ⅰ group. (gm) in Treat Ⅲ group and (gm) in Treat Ⅳ group. There was significance in the analgesic effects between Control group and Treat group(p<0.05) 3. The number of WBC was (㎕) in control Group, (㎕) in Treat Ⅰ group, (㎕) in Treat Ⅱ Group and (㎕) in Treat Ⅳ group. There was significance in the number of WBC between Control group and Treat group(p<0.05) 4. The content of total protein in the blood serum were g/dl in control group, g/dl in Treat I group, g/dl in Treat Ⅲ group and g/dl in Treat IV group. There was significance in The content of total protein in the blood serum between Control group and Treat group(p<0.05) 5. The contests of albumin in the blood serum were g/dl in the Control group, g/dl in Treat Ⅰ group, g/dl in Treat Ⅱ group, g/dl in Treat Ⅲ group, g/dl in Treat IV group. There was no significance in The content of albumin in the blood serum between Control group and Treat group(p<0.05) 6. The contests of globulin in the blood semm were g/dl in the Control group, g/dl in Treat Ⅰ group, g/dl in Treat IV group. There was significance in The content of globulin in the blood serum between Control group and Treat group(p<0.05) 7. The numbers of RA factor were IU/ml in Control group and IU/ml in Treat Ⅱ group. There was significance inThe numbers of RA factor between Control group and Treat group(p<0.05) 8. The numbers of platelet were /㎕ in Control group, /㎕ in Treat Ⅰ group, /㎕ in Treat Ⅱ group, /㎕l in Treat Ⅲ group, /㎕ in Treat Ⅳ group. There was no significance in The numbers of platelet between Control group and Treat group(p<0.05) 9. The quantity of CRP were mg/ml in Control group, mg/ml in Treat Ⅰ group, mg/ml in Treat Ⅱ group, mg/ml in Treat..... 
546 |a EN 
546 |a KO 
690 |a Cervi Comu Ex 
690 |a Cervi Comu Herbal-acupuncture 
690 |a Adjuvant Arthrits113 
690 |a Medicine 
690 |a R 
690 |a Miscellaneous systems and treatments 
690 |a RZ409.7-999 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacopuncture, Vol 5, Iss 1, Pp 113-133 (2002) 
787 0 |n http://dx.doi.org/10.3831/KPI.2002.5.1.113 
787 0 |n https://doaj.org/toc/2093-6966 
787 0 |n https://doaj.org/toc/2234-6856 
856 4 1 |u https://doaj.org/article/99b3436a7b2e4f1c85c1eb02d87e1192  |z Connect to this object online.